Anti-HLA E antibody [MEM-E/08]
| Name | Anti-HLA E antibody [MEM-E/08] |
|---|---|
| Supplier | Abcam |
| Catalog | ab11821 |
| Prices | $384.00 |
| Sizes | 100 µg |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Clone | MEM-E/08 |
| Applications | WB FC IP |
| Species Reactivities | Human |
| Antigen | Bacterially expressed recombinant HLA-E refolded with beta2-microglobulin and peptide |
| Description | Mouse Monoclonal |
| Gene | HLA-E |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab11821 staining HLA E in Human K562 cells by Flow Cytometry. The sample was incubated with the primary antibody, (1/50), for 1 hour at 24°C. Ab6785(1/100) was used as secondary antibody. Gating Strategy: Isotrope controlSee Abreview
![Anti-HLA E antibody [MEM-E/08] (ab11821) at 1 µg/ml + Spleen (Human) Tissue Lysate - adult normal tissue (ab29699) at 10 µgSecondaryGoat polyclonal Secondary Antibody to Mouse IgG - H&L (HRP), pre-adsorbed at 1/3000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_3/2672_HLA-E-Primary-antibodies-ab11821-4.jpg)
Anti-HLA E antibody [MEM-E/08] (ab11821) at 1 µg/ml + Spleen (Human) Tissue Lysate - adult normal tissue (ab29699) at 10 µgSecondaryGoat polyclonal Secondary Antibody to Mouse IgG - H&L (HRP), pre-adsorbed at 1/3000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.
Product References
Evaluation of gene delivery strategies to efficiently overexpress functional - Evaluation of gene delivery strategies to efficiently overexpress functional
Boura JS, Vance M, Yin W, Madeira C, Lobato da Silva C, Porada CD, Almeida-Porada G. Mol Ther Methods Clin Dev. 2014 Sep;2014(1). pii: 14041.
Modulation of human mesenchymal stem cell immunogenicity through forced - Modulation of human mesenchymal stem cell immunogenicity through forced
Soland MA, Bego MG, Colletti E, Porada CD, Zanjani ED, St Jeor S, Almeida-Porada G. PLoS One. 2012;7(5):e36163.
Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against - Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against
Heidenreich S, Zu Eulenburg C, Hildebrandt Y, Stubig T, Sierich H, Badbaran A, Eiermann TH, Binder TM, Kroger N. Clin Dev Immunol. 2012;2012:652130.
Vascular endothelial growth factor C facilitates immune tolerance and - Vascular endothelial growth factor C facilitates immune tolerance and
Kalkunte SS, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S. J Immunol. 2009 Apr 1;182(7):4085-92.
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple - Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple
Tennakoon DK, Mehta RS, Ortega SB, Bhoj V, Racke MK, Karandikar NJ. J Immunol. 2006 Jun 1;176(11):7119-29.
The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected - The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected
Brooks CR, Elliott T, Parham P, Khakoo SI. J Immunol. 2006 Jan 15;176(2):1141-7.